Decrease of the immunophilin FKBP52 accumulation in human brains of alzheimer's disease and FTDP-17

Journal of Alzheimer's Disease

Volumn 29, Issue 2, 2012, Pages 471-483

  Giustiniani, Julien ^a   Sineus, Marlène ^a   Sardin, Elodie ^a   Dounane, Omar ^a   Panchal, Maï ^b   Sazdovitch, Véronique ^b   Duyckaerts, Charles ^b   Chambraud, Béatrice ^a   Baulieu, Etienne Emile ^a  

^a Universite Paris Sud   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Alzheimer's disease; FKBP52; frontal cortex; frontotemporal dementia with Parkinsonism; immunophilins; tau; tauopathies

Indexed keywords

FK 506 BINDING PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOPHILIN; ISOPROTEIN; MESSENGER RNA; NEURON SPECIFIC ENOLASE; TAU PROTEIN;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; BRAIN CORTEX; CHILD; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOFLUORESCENCE; INTERNEURON; MALE; PARKINSONISM; PARKINSONISM LINKED TO CHROMOSOME 17; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TAUOPATHY;

EID: 84859392758     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111895     Document Type: Article

References (49)

1. Lebeau MC, Massol N, Herrick J, Faber LE, Renoir JM, Radanyi C, Baulieu EE (1992) P59, an hsp 90-binding protein. Cloning and sequencing of its cDNA and preparation of a peptide-directed polyclonal antibody. J Biol Chem 267, 4281-4284.
2. Tai PK, Maeda Y, Nakao K, Wakim NG, Duhring JL, Faber LE (1986) A 59-kilodalton protein associated with progestin, estrogen, androgen, and glucocorticoid receptors. Biochemistry 25, 5269-5275. (Pubitemid 17016541)
3. Renoir JM, Radanyi C, Faber LE, Baulieu EE (1990) The non-DNA-binding heterooligomeric form of mammalian steroid hormone receptors containsahsp90-bound 59-kilodalton protein. J Biol Chem 265, 10740-10745.
4. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin. A and FKBP-FK506 complexes. Cell 66, 807-815. (Pubitemid 121001714)
5. Schreiber SL (1991) Chemistry and biology of the immunophilins and their immunosuppressiveligands. Science 251, 283-287. (Pubitemid 21916873)
6. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces, I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 40, 1249-1255. (Pubitemid 17138109)
7. Vézina C, Kudelski A, Sehgal SN (1975) Rapamycin (AY-22, 989), a new antifungal antibiotic, I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 28, 721-726.
8. Steiner JP, Dawson TM, Fotuhi M, Glatt CE, Snowman AM, Cohen N, Snyder SH (1992) High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358, 584-587.
9. Lu KP, Zhou XZ (2007) The prolyl isomerase PIN1: A pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8, 904-916. (Pubitemid 47622559)
10. Chambraud B, Rouvière-Fourmy N, Radanyi C, Hsiao K, Peattie DA, Livingston DJ, Baulieu EE (1993) Overexpres-sion of p59-HBI (FKBP59), full length and domains, and characterization of PPlase activity. Biochem Biophys Res Commun 196, 160-166. (Pubitemid 23309488)
11. Schiene C, Fischer G (2000) Enzymes that catalyse the restructuring of proteins. Curr Opin Struct Biol 10, 40-45. (Pubitemid 30099325)
12. Gold BG (1999) FK506 and the role of the immunophilin FKBP-52innerve regeneration.Drug Metab Rev31, 649-663. (Pubitemid 29390405)
13. Brecht S, Schwarze K, Waetzig V, Christner C, Heiland S, Fischer G, Sartor K, Herdegen T (2003) Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain. Neuroscience 120, 1037-1048. (Pubitemid 36966654)
14. Sanokawa-Akakura R, Cao W, Allan K, Patel K, Ganesh A, Heiman G, Burke R, Kemp FW, Bogden JD, Camakaris J, Birge RB, Konsolaki M (2010) Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila. PLoS One 5, e8626.
15. Shim S, Yuan JP, Kim JY, Zeng W, Huang G, Milshteyn A, Kern D, Muallem S, Ming GL, Worley PF (2009) Peptidyl-prolyl isomerase FKBP52 controls chemotropic guidance of neuronal growth cones via regulationofTRPC1channelopen-ing. Neuron 64, 471-483.
16. Gerard M, Deleersnijder A, Daniëls V, Schreurs S, Munck S, Reumers V, Pottel H, Engelborghs Y, Van den Haute C, Taymans JM, Debyser Z, Baekelandt V (2010) Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology. J Neurosci 30, 2454-2463.
17. Deleersnijder A, Van Rompuy AS, Desender L, Pottel H, Buee L, Debyser Z, Baekelandt V, Gerard M (2011) Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of {alpha}-synuclein aggregation. J Biol Chem 286, 26687-26701.
18. Fusco D, Vargiolu M, Vidone M, Mariani E, Pennisi LF, Bonora E, Capellari S, Dirnberger D, Baumeister R, Mar-tinelli P, Romeo G (2010) The RET51/FKBP52 complex and its involvement in Parkinson disease. Hum Mol Genet 19, 2804-2816.
19. Chambraud B, Belabes H, Fontaine-Lenoir V, Fellous A, Baulieu EE (2007) The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation. FASEB J 11, 2787-2797. (Pubitemid 47372746)
20. Chambraud B, Sardin E, Giustiniani J, Dounane O, Schumacher M, Goedert M, Baulieu EE (2010) A role for FKBP52 in tau protein function. Proc Natl Acad Sci USA 107, 2658-2663.
21. Cleveland DW, Hwo SY, Kirschner MW (1977) Purificationof tau, amicrotubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 116, 207-225. (Pubitemid 8215104)
22. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72, 1858-1862.
23. Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33, 95-130.
24. Johnson GV, Stoothoff WH (2004) Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 117 (Pt 24), 5721-5729. (Pubitemid 40123939)
25. Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev 84, 361-384. (Pubitemid 38365487)
26. Goedert M, Jakes R (1990) Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 9, 4225-4230. (Pubitemid 120025977)
27. Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 85, 4051-4045.
28. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegener-ative tauopathies. Annu Rev Neurosci 24, 1121-1159.
29. Ballatore C, Lee VMY, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8, 663-672. (Pubitemid 47283144)
30. Goedert M, Spillantini MG, Cairns NJ, Crowther RA (1992) Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168.
31. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118, 5-36.
32. Buée L, Delacourte A (1999) Comparative biochemistryoftau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 9, 681-693. (Pubitemid 29470961)
33. Goedert M, Jakes R (2005) Mutations causing neurodegener-ative tauopathies. Biochim Biophys Acta 1739, 240-250.
34. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW (2004) Caspase-cleavage of tau is anearly eventin Alzheimer disease tangle pathology. J Clin Invest 114, 121-130. (Pubitemid 39071651)
35. Guillozet-Bongaarts AL, Garcia-Sierra F, Reynolds MR, Horowitz PM, Fu Y, Wang T, Cahill ME, Bigio EH, Berry RW, Binder LI (2005) Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease. Neurobiol Aging 26, 1015-1022. (Pubitemid 40312665)
36. Brunden KR, Trojanowski JQ, Lee VM (2008) Evidence that non-fibrillar taucauses pathologylinkedtoneurodegeneration and behavioral impairments. J Alzheimers Dis 14, 393-399.
37. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
38. Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800. (Pubitemid 34663580)
39. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, Consortium on DLB (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 65, 1863-1872. (Pubitemid 43970103)
40. Gutala RV, Reddy PH (2004) The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains. J Neurosci Methods 132, 101-107. (Pubitemid 37543755)
41. Sugata H, Matsuo K, Nakagawa T, Takahashi M, Mukai H, Ono Y, Maeda K, Akiyama H, Kawamata T (2009) A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles. Neurosci Lett 459, 96-99.
42. Kraemer BC, Burgess JK, Chen JH, Thomas JH, Schellenberg GD (2006) Molecular pathways that influence human tau-induced pathology in Caenorhabditiselegans. Hum Mol Genet 15, 1483-1496.
43. Wang Y, Martinez-Vicente M, Krüger U, Kaushik S, Wong E, Mandelkow EM, Cuervo AM, Mandelkow E (2009) Tau fragmentation, aggregation and clearance: The dual role of lysosomal processing. Hum Mol Genet 18, 4153-4170.
44. Liu YH, Wei W, Yin J, Liu GP, Wang Q, Cao FY, Wang JZ (2009) Proteasome inhibition increases tau accumulation independent of phosphorylation. Neurobiol Aging 30, 1949-1961.
45. Dolan PJ, Johnson GV (2010) A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J Biol Chem 285, 21978-21987.
46. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, Kim J, Dillmann WH, Browne SE, Hall A, Voellmy R, Tsuboi Y, Dawson TM, Wolozin B, Hardy J, Hutton M (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet 13, 703-714. (Pubitemid 38455958)
47. Bose S, Weikl T, Bügl H, Buchner J (1996) Chaperone function of Hsp90-associated proteins. Science 274, 1715-1717. (Pubitemid 26414904)
48. Wu B, Li P, Liu Y, Lou Z, Ding Y, Shu C, Ye S, Bartlam M, Shen B, Rao Z (2004) 3D structure of human FK506-binding protein 52: Implications for the assembly of the glucocorti-coid receptor/Hsp90/immunophilin heterocomplex.Proc Natl Acad Sci USA 101, 8348-8453.
49. Jinwal UK, Koren J 3rd, Borysov SI, Schmid AB, Abisambra JF, Blair LJ, Johnson AG, Jones JR, Shults CL, O'Leary JC 3rd, Jin Y, Buchner J, Cox MB, Dickey CA (2010) The Hsp90 cochaperone, FKBP51, increases tau stability and polymerizes microtubules. J Neurosci 30, 591-599.